ChromoCure publishes results of cervical cancer study using its Chromosomal Scanner Technology ChromoCure, Inc. is very happy to announce the publication of the Cervical Cancer tumor Study, PRE-CLINICAL SYSTEM Functionality and TESTING ASSESSMENT, conducted together with a significant international Cancer Clinic. The study analyzed samples supplied by the Cancer Clinic using its Proprietary Chromosomal Scanner Technology the efficacy of using an automated system to detect aneuploid cells in real-world specimens; 2) the detection of aneuploid cells is diagnostic of cervical lesions; and 3) the scanner’s superb performance at not only detecting cancer but achieving the near theoretical maximum contract with error containing data.Dr. Urs has been developing particularly engineered animal versions as uniquely powerful equipment for understanding the mind mechanisms that provide rise to schizophrenia and additional brain disorders. He’ll present his latest focus on the dopamine D2 receptor , a common focus on for antipsychotics, using pet models to check antipsychotic efficacy with the purpose of developing new, far better therapeutic strategies.D., Ph.D. , 2013 Goldman-Rakic Prize for Exceptional Accomplishment in Cognitive Neuroscience, Stanford University, Howard Hughes Medical Institute Investigator. Dr. Deisseroth will show two new systems he is rolling out for learning about mind dysfunction and function.